Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemiaHagop Kantarjian, Emil J. Freireich, Farhad Ravandi et al.|Blood|2010Cited by 399
Fludarabine: a new agent with marked cytoreductive activity in untreated chronic lymphocytic leukemia.Michael J. Keating, K. B. McCredie, H. Kantarjian et al.|Journal of Clinical Oncology|1991Cited by 249
Cytogenetic pattern in acute myelogenous leukemia: a major reproducible determinant of outcome.Michael J. Keating, Emil J. Freireich, Terry L. Smith et al.|PubMed|1988Cited by 218
Prognostic factors in acute leukemia.E. A. Gehan, K. B. McCredie, Terry L. Smith et al.|PubMed|1976Cited by 112
Phase II trial of mitoxantrone in refractory acute leukemia.Elihu H. Estey, Emil J. Freireich, Michael J. Keating et al.|PubMed|1983Cited by 64